BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Weekes J, Lam AKY, Sebesan S, Ho YH. Irinotecan therapy and molecular targets in colorectal cancer: A systemic review. World J Gastroenterol 2009; 15(29): 3597-3602 [PMID: 19653336 DOI: 10.3748/wjg.15.3597]
URL: https://www.wjgnet.com/1007-9327/full/v15/i29/3597.htm
Number Citing Articles
1
Moriah Wright, Jenifer S. Beaty, Charles A. Ternent. Molecular Markers for Colorectal CancerSurgical Clinics of North America 2017; 97(3): 683 doi: 10.1016/j.suc.2017.01.014
2
Yong-E. Gao, Shuang Bai, Xiaoxiao Shi, Meili Hou, Xiaoqian Ma, Tian Zhang, Bo Xiao, Peng Xue, Yuejun Kang, Zhigang Xu. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapyColloids and Surfaces B: Biointerfaces 2018; 170: 488 doi: 10.1016/j.colsurfb.2018.06.054
3
YU GU, SHEN-LIN LIU, WEN-ZHENG JU, CHANG-YIN LI, PENG CAO. Analgesic-antitumor peptide induces apoptosis and inhibits the proliferation of SW480 human colon cancer cellsOncology Letters 2013; 5(2): 483 doi: 10.3892/ol.2012.1049
4
Shoichi Matsukuma, Haruhiro Saito, Kozo Yamada, Naoyuki Okamoto, Tomokazu Ishikawa, Mitsuyo Yoshihara, Shiro Koizume, Yuji Sakuma, Yohei Miyagi. Simple and precise detection of UGT1A1 polymorphisms with a modified loop-hybrid mobility shift assay using Cy5-labeled loop probesClinica Chimica Acta 2011; 412(17-18): 1668 doi: 10.1016/j.cca.2011.05.021
5
Jeffrey S Ross. Biomarker-based selection of therapy for colorectal cancerBiomarkers in Medicine 2011; 5(3): 319 doi: 10.2217/bmm.11.38
6
Rachel M. McQuade, Vanesa Stojanovska, Elizabeth L. Donald, Ahmed A. Rahman, Dean G. Campelj, Raquel Abalo, Emma Rybalka, Joel C. Bornstein, Kulmira Nurgali. Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric NeuronsFrontiers in Physiology 2017; 8 doi: 10.3389/fphys.2017.00391
7
Yu Zhang, Hongyu Zhang, Pan He, Xuan Yi, Xinming Liu, Chunsheng Xiao. A PEGylated alternating copolymeric prodrug of sulfur dioxide with glutathione responsiveness for Irinotecan deliveryJournal of Materials Chemistry B 2021; 9(1): 187 doi: 10.1039/D0TB02097D
8
Maria Rosaria di Nunzio, Yasmin Douhal, Juan Angel Organero, Abderrazzak Douhal. Structural and photodynamic properties of the anti-cancer drug irinotecan in aqueous solutions of different pHsPhysical Chemistry Chemical Physics 2018; 20(20): 14182 doi: 10.1039/C8CP01134F
9
Jiafeng Tong, Ying Shen, Zhenghua Zhang, Ye Hu, Xu Zhang, Li Han. Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathwayBioscience Reports 2019; 39(5) doi: 10.1042/BSR20190452
10
Ivo Doskočil, Anna Hošťálková, Marcela Šafratová, Nina Benešová, Jaroslav Havlík, Radim Havelek, Jiří Kuneš, Karel Královec, Jakub Chlebek, Lucie Cahlíková. Cytotoxic activities of Amaryllidaceae alkaloids against gastrointestinal cancer cellsPhytochemistry Letters 2015; 13: 394 doi: 10.1016/j.phytol.2015.08.004
11
Jeffrey S. Ross, Jorge Torres-Mora, Nikhil Wagle, Timothy A. Jennings, David M. Jones. Biomarker-Based Prediction of Response to Therapy for Colorectal CancerAmerican Journal of Clinical Pathology 2010; 134(3): 478 doi: 10.1309/AJCP2Y8KTDPOAORH
12
Émilie C. Lefort, Jonathan Blay. The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cellsClinical & Experimental Metastasis 2011; 28(4): 337 doi: 10.1007/s10585-010-9364-6
13
Hossieny Ibrahim, Yassien Temerk. Gold nanoparticles anchored graphitized carbon nanofibers ionic liquid electrode for ultrasensitive and selective electrochemical sensing of anticancer drug irinotecanMicrochimica Acta 2020; 187(10) doi: 10.1007/s00604-020-04560-9
14
Xing He, Huanrong Lan, Ketao Jin, Fanlong Liu. Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatmentFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1237764
15
Diana C. DeLucia, Thomas M. Cardillo, Lisa Ang, Mark P. Labrecque, Ailin Zhang, James E. Hopkins, Navonil De Sarkar, Ilsa Coleman, Rui M. Gil da Costa, Eva Corey, Lawrence D. True, Michael C. Haffner, Michael T. Schweizer, Colm Morrissey, Peter S. Nelson, John K. Lee. Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate CancerClinical Cancer Research 2021; 27(3): 759 doi: 10.1158/1078-0432.CCR-20-3396
16
Anna Chruścik, Vinod Gopalan, Alfred King-yin Lam. The clinical and biological roles of transforming growth factor beta in colon cancer stem cells: A systematic reviewEuropean Journal of Cell Biology 2018; 97(1): 15 doi: 10.1016/j.ejcb.2017.11.001
17
Luigi Grassi, Maria Giulia Nanni, Yosuke Uchitomi, Michelle Riba. Depression and Cancer2010; : 151 doi: 10.1002/9780470972533.ch7
18
J.-M. Escoffre, A. Novell, S. Serrière, T. Lecomte, A. Bouakaz. Irinotecan Delivery by Microbubble-Assisted Ultrasound: In Vitro Validation and a Pilot Preclinical StudyMolecular Pharmaceutics 2013; 10(7): 2667 doi: 10.1021/mp400081b
19
Pankajini Mallick, Pranav Shah, Adarsh Gandhi, Romi Ghose. Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in miceLife Sciences 2015; 139: 132 doi: 10.1016/j.lfs.2015.08.017
20
Zhaohuan Li, Chunxi Liu, Chenglei Li, Fangqing Wang, Jianhao Liu, Zengjuan Zheng, Jingliang Wu, Bo Zhang. Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapyJournal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01172-0
21
Elisa Checa-Chavarria, Eva Rivero-Buceta, Miguel Angel Sanchez Martos, Gema Martinez Navarrete, Cristina Soto-Sánchez, Pablo Botella, Eduardo Fernández. Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma MultiformeMolecular Pharmaceutics 2021; 18(4): 1558 doi: 10.1021/acs.molpharmaceut.0c00968
22
Xiangge Tian, Meirong Zhou, Jing Ning, Xiaopeng Deng, Lei Feng, Huilian Huang, Dahong Yao, Xiaochi Ma. The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2Journal of Enzyme Inhibition and Medicinal Chemistry 2021; 36(1): 737 doi: 10.1080/14756366.2021.1896500
23
Vinod Gopalan, Robert A. Smith, Mohammad R. Nassiri, Koichi Yasuda, Ali Salajegheh, Sang Y. Kim, Yik-Hong Ho, Stephen Weinstein, Johnny C.-O. Tang, Alfred K.-Y. Lam. GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic featuresHuman Pathology 2010; 41(7): 1009 doi: 10.1016/j.humpath.2009.11.014
24
Ming-Cheng Chen, Nien-Hung Lee, Tsung-Jung Ho, Hsi-Hsien Hsu, Chia-Hua Kuo, Wei-Wen Kuo, Yueh-Min Lin, Fuu-Jen Tsai, Chang-Hai Tsai, Chih-Yang Huang. Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cellsCancer Letters 2014; 349(1): 51 doi: 10.1016/j.canlet.2014.03.023
25
Takeshi Kinoshita, Hajime Higuchi, Ayano- Kabashima-, Gen Sakai, Yasuo Hamamoto, Hiromasa Takaishi, Takanori Kanai. Analysis of Sensitivity and Cell Death Pathways Mediated by Anti-cancer Drugs Using Three-dimensional Culture SystemInternational Journal of Cancer Research 2017; 14(1): 1 doi: 10.3923/ijcr.2018.1.12
26
Qing Wen, Paul O'Reilly, Philip D Dunne, Mark Lawler, Sandra Van Schaeybroeck, Manuel Salto-Tellez, Peter Hamilton, Shu-Dong Zhang. Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapiesBMC Systems Biology 2015; 9(S5) doi: 10.1186/1752-0509-9-S5-S4
27
Xiuyan Yang, Jie Zhong, Qiufen Zhang, Li Feng, Zhen Zheng, Jian Zhang, Shaoyong Lu. Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer TherapyFrontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.662579
28
Gregorio Bonazza, Stefano Tartaggia, Giuseppe Toffoli, Federico Polo, Salvatore Daniele. Voltammetric behaviour of the anticancer drug irinotecan and its metabolites in acetonitrile. Implications for electrochemical therapeutic drug monitoringElectrochimica Acta 2018; 289: 483 doi: 10.1016/j.electacta.2018.09.094
29
Jing Zhao, Yixin Lu, Han-Ming Shen. Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cellsCancer Letters 2012; 314(1): 8 doi: 10.1016/j.canlet.2011.09.040
30
Pengfei Jiang, Rajesh Mukthavavam, Ying Chao, Ila Sri Bharati, Valentina Fogal, Sandra Pastorino, Xiuli Cong, Natsuko Nomura, Matt Gallagher, Taher Abbasi, Shireen Vali, Sandeep C Pingle, Milan Makale, Santosh Kesari. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugsJournal of Translational Medicine 2014; 12(1) doi: 10.1186/1479-5876-12-13
31
Christina V. Angeles, Ana Velez, Jordan Rios, Bernadette Laxa, David Shum, Penelope D. Ruiz, Yawei Shen, Irina Ostrovnaya, Rodrigo Gularte-Mérida, Benjamin A. Nacev, Mark A. Dickson, Hakim Djaballah, Tomoyo Okada, Samuel Singer. A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated LiposarcomaClinical Cancer Research 2022; 28(1): 175 doi: 10.1158/1078-0432.CCR-19-2486
32
ChunLei Li, JingXia Cui, CaiXia Wang, YanHui Li, Lan Zhang, Xian Xiu, YongFeng Li, Na Wei, Li Zhang, Ping Wang. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulationJournal of Pharmacy and Pharmacology 2011; 63(6): 765 doi: 10.1111/j.2042-7158.2011.01272.x
33
K Reece, W Figg. Handbook of Therapeutic Biomarkers in Cancer2013; : 353 doi: 10.1201/b15029-13
34
Sarah R. Mudd, Kimberley D. Holich, Martin J. Voorbach, Todd B. Cole, David R. Reuter, Paul Tapang, Gail Bukofzer, Arunava Chakravartty, Cherrie K. Donawho, Joann P. Palma, Gerard B. Fox, Mark Day, Yanping Luo. Pharmacodynamic Evaluation of Irinotecan Therapy by FDG and FLT PET/CT Imaging in a Colorectal Cancer Xenograft ModelMolecular Imaging and Biology 2012; 14(5): 617 doi: 10.1007/s11307-011-0529-8
35
Afraa Mamoori, Riajul Wahab, Jelena Vider, Vinod Gopalan, Alfred King-yin Lam. The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancerGene 2019; 697: 165 doi: 10.1016/j.gene.2019.02.046
36
Alan J. Kim, David S. Hong, Goldy C. George. Dietary influences on symptomatic and non-symptomatic toxicities during cancer treatment: A narrative reviewCancer Treatment Reviews 2022; 108: 102408 doi: 10.1016/j.ctrv.2022.102408
37
Martina Tommasini, Elena Pellizzoni, Valentina Iacuzzi, Elena Marangon, Paola Posocco, Cristina Forzato, Paolo Bertoncin, Giuseppe Toffoli, Marina Resmini, Federico Berti. Fluorescent Imprinted Nanoparticles for the Effective Monitoring of Irinotecan in Human PlasmaNanomaterials 2020; 10(9): 1707 doi: 10.3390/nano10091707
38
Yoichi Ozawa, Kazutomi Kusano, Takashi Owa, Akira Yokoi, Makoto Asada, Kentaro Yoshimatsu. Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatmentCancer Chemotherapy and Pharmacology 2012; 69(5): 1353 doi: 10.1007/s00280-012-1844-8
39
Young-Soon Na, Kyung-Ah Jung, Seung-Mi Kim, Yong Sang Hong, Min-Hee Ryu, Se Jin Jang, Dae Hyuk Moon, Dong-Hyung Cho, Jin Cheon Kim, Jung Shin Lee, Tae Won Kim. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer modelsCancer Chemotherapy and Pharmacology 2011; 68(2): 389 doi: 10.1007/s00280-010-1495-6
40
Carly Griffin, Aditya Karnik, James McNulty, Siyaram Pandey. Pancratistatin Selectively Targets Cancer Cell Mitochondria and Reduces Growth of Human Colon Tumor XenograftsMolecular Cancer Therapeutics 2011; 10(1): 57 doi: 10.1158/1535-7163.MCT-10-0735